⚠ For Research Use Only — Not For Human Consumption — Must Be 21+ To Purchase

Tesamorelin is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analogue. Approved by the FDA as Egrifta or Egrifta SV, it is primarily prescribed to reduce excess visceral fat (deep belly fat surrounding internal organs) in HIV patients with lipodystrophy.
⚠ For research and laboratory use only. Not for human consumption. Must be 21+ to purchase.
Peptide
Tesamorelin
Purity
≥99% Purity
Form
Lyophilised Powder
Storage
-20°C (long term), 4°C (short term)
Testing
HPLC, Mass Spectrometry